GO
Loading...

GlaxoSmithKline PLC

More

  • Lilly, Pfizer & The Economies of ED Thursday, 24 Jul 2008 | 11:25 AM ET

    So, yesterday I posited a theory that the weak American economy might be hurting sales growth of erectile dysfunction drugs. I wondered whether men might be cutting their pills in half and/or not filling their expensive prescriptions if they're having to tighten their belts.

  • Oil Drop Lifts Stocks Wednesday, 23 Jul 2008 | 5:49 PM ET

    The Dow fought its way higher on Wednesday as oil prices fell and positive sentiment swelled on hopes that lawmakers will soon approve a rescue plan for Fannie and Freddie.

  • Stocks End Higher as Oil Falls Below $125 Wednesday, 23 Jul 2008 | 5:13 PM ET

    Stocks finished higher as oil broke below the key $125 a barrel mark.

  • Dow Rebounds as Oil Falls Below $125 Wednesday, 23 Jul 2008 | 4:01 PM ET

    Stocks advanced, boosted by a further drop in oil following the inventory report and expectations that the House would pass the Fannie Mae-Freddie Mac rescue plan.

  • See-Saw Market: Stocks Rise as Oil Falls Wednesday, 23 Jul 2008 | 1:57 PM ET

    Stocks advanced, boosted by a further drop in oil following the inventory report and expectations that the House would pass the Fannie Mae-Freddie Mac rescue plan.

  • Is Pfizer's Viagra "Sagging" With The Economy? Wednesday, 23 Jul 2008 | 12:18 PM ET

    On the Pfizer earnings conference call this morning Chairman and CEO Jeff Kindler kicked things off by calling this a "time of great uncertainty in the world economy and capital markets and significant challenges in our industry."

  • Stocks Rise as Oil Drops More Than $1 Wednesday, 23 Jul 2008 | 11:44 AM ET

    Stocks advanced, boosted by a further drop in oil following the inventory report and expectations that the House would pass the Fannie Mae-Freddie Mac rescue plan.

  • Glaxo Earnings Rise 13%, Cautious on Outlook Wednesday, 23 Jul 2008 | 8:19 AM ET

    GlaxoSmithKline's new chief executive set out plans to make the world's second largest drug maker a broader business with lower costs, but kept a cautious view on short-term prospects that knocked its shares.   

  • Big Pharma Is Scrambling To Buy More Biotech Firms Monday, 21 Jul 2008 | 11:11 AM ET

    Roche Holdings' $43.7 billion bid to buy the rest of Genentech highlights drugmakers' growing reliance on biotech products.

  • Roche Offers to Buy Out Genentech for $43.7 Billion Monday, 21 Jul 2008 | 6:33 AM ET

    Swiss drugmaker Roche Holding offered to acquire all outstanding shares in its U.S. partner Genentech for $43.7 billion in cash to reinforce its position in cancer medicines.

  • Lilly's Sex Survey: Will It Have Desired Effect On Cialis? Wednesday, 16 Jul 2008 | 12:31 PM ET
    Lilly

    More than ten years after Pfizer brought Viagra to market and brought erectile dysfunction out of the closet a new survey says a lot of men are still too embarrassed to talk about impotence with their doctor.

  • UBS And Its Guarded Outlook For Merck's Gardasil Monday, 7 Jul 2008 | 11:14 AM ET

    Shares of Merck, which have lost more than a third of their value so far this year, are under continued pressure this morning. They were at 60 bucks in early January. Today they're trading around $37. Big pharma analyst Rupesh Patel at UBS is downgrading the Dow component from Buy to Neutral because he thinks it's gonna be "range-bound near-term"...

  • Biopharma Analyst Musical Chairs Wednesday, 2 Jul 2008 | 11:16 AM ET

    In the world of nearly 400 publicly-traded biotechs, analyst coverage is especially important. Many of the firms are micro caps and when an analyst initiates coverage it can help put a baby biotech on investor and reporter radar screens.

  • Dealing With a Decimated Dow Thursday, 26 Jun 2008 | 6:30 PM ET

    Cramer offers his plan of action to handle a 358-point decline.

  • Dow Falls Below 12,000 Friday, 20 Jun 2008 | 5:53 PM ET

    The Dow closed sharply lower Friday, registering its third triple-digit loss in four sessions. What's the "Word on the Street?"

  • My ASCO Fiasco Tuesday, 3 Jun 2008 | 8:58 AM ET

    This year, for the first time ever, ASCO agreed to let CNBC broadcast live from inside McCormick Place. It took years of reasoning, pleading, nagging and complaining to get inside. But finally, ASCO consented. In the past, the scientific organization has tried to keep more than an arm's distance from the financial media.

  • Inflation, Credit Worries Dent Europe Stocks Tuesday, 27 May 2008 | 1:01 PM ET

    A bout of risk aversion dented European stocks on Tuesday as jitters grew over potential credit-related problems at banks and inflation, while typically defensive stocks such as pharmaceuticals and food rallied.

  • Are Impotence Drugs Good for Your Heart? Monday, 19 May 2008 | 5:43 PM ET

    A study claims "the time has come" for researchers to study ED drugs as preventive medicine for the heart.

  • Pfizer And Amgen Trade "Political" Places Monday, 19 May 2008 | 10:51 AM ET
    Amgen

    Up until last month, AMGN had been atop the list of pharmaceutical manufacturer donors and PFE was in a close second. But the CRP says they flip-flopped in the most recent month that figures are available. So far, in the 2008 election cycle, Pfizer's given $862,000 to candidates and Amgen has forked over $852,000.

  • Biotech's Big Night Thursday, 15 May 2008 | 6:38 PM ET

    Traders will be glued to the web Thursday night as thousands of cancer studies go online. What’s the trade as these studies potentially send shock waves through biotech stocks on Friday morning?